Osteoclastogenesis Inhibitory Factor

Osteoclastogenesis Inhibitory Factor Uses, Dosage, Side Effects, Food Interaction and all others data.

Recombinant osteoprotegerin (Osteoclastogenesis Inhibitory Factor) is a recombinant OPG construct developed as a potential therapeutic agent in the treatment of bone disease.

Table Of contents

• Osteoclastogenesis Inhibitory Factor
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Osteoclastogenesis Inhibitory Factor
Generic	AMGN-0007
AMGN-0007 Other Names	Osteoclastogenesis inhibitory factor, Osteoprotegerin recombinant, rOPG
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in osteoporosis and bone metastases.

Innovators Monograph

You find simplified version here Osteoclastogenesis Inhibitory Factor